GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Alexion Pharmaceuticals, Inc. (ALXN) [hlAlert]

Rating:
Equal Weight
ALXN
up 98.14 %

Alexion Pharmaceuticals, Inc. (ALXN) rated Equal Weight with price target $205 by Barclays

Posted on: Monday,  Sep 14, 2015  1:25 PM ET by Barclays

Barclays rated Equal Weight Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) on 09/14/2015. Previously Barclays rated Overweight Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) on
04/25/2012., when the stock price was $90.75. Since then, Alexion Pharmaceuticals, Inc. has gained 98.15% as of 12/11/2015's recent price of $179.82.
If you would have followed the previous Barclays's recommendation on ALXN, you would have gained 98.14% of your investment in 1325 days.

Alexion Pharmaceuticals develops pharmaceutical products for the treatment of heart disease, and inflammation, diseases of the immune system and cancer in humans. The company's lead product candidates are genetically altered antibodies that target specific diseases which arise when the human immune system induces undesired inflammation in the human body. These candidates are designed to block components of the human immune system which cause undesired inflammation while allowing beneficial components of the immune system to remain functional.

Barclays
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/14/2015 1:25 PM Buy
None
166.26 205.00
as of 8/27/2015
1 Week down  -5.16 %
1 Month down  -5.81 %
3 Months up  11.21 %
1 YTD up  35.32 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/6/2014 12:25 PM Buy
None
172.70 193.00
1/31/2014 1:25 PM Buy
None
158.32 181.00
1/10/2014 1:25 PM Buy
None
134.56 141.00
7/26/2013 1:25 PM Buy
None
110.05 121.00
4/25/2012 2:25 PM Buy
None
90.75 104.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy